April 10, 2021
Expand Targeted Therapy for Lung Cancer
Seeking to expand targeted therapy for lung cancer, Dr. Alice Berger, a recipient of a LCFA lung cancer research grant, has also received a NIH MERIT Award.
Fred Hutch News Service
Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
April 10, 2021
Seeking to expand targeted therapy for lung cancer, Dr. Alice Berger, a recipient of a LCFA lung cancer research grant, has also received a NIH MERIT Award.
Fred Hutch News Service
February 19, 2021
Antibody hinders EGFR lung cancer: Johnson&Johnson’s drug shows succes in hindering tumor growth in 74% of lung cancer patients with EGFR mutations.
FIERCEBiotech
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.